Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nokia Corp (NOK) vs Oscar Health Inc (OSCR) Price & Performance

Nokia CorpTrade
Oscar Health IncTrade

Price performance (Past 24H)

Key statistics

Nokia Corp vs Oscar Health Inc — how do they compare? Nokia Corp trades at $10.36 (market cap $56.99B), while Oscar Health Inc trades at $33.59 (market cap $10.22B). The key difference: Nokia Corp is far larger — about 5.6× Oscar Health Inc's market cap, and Nokia Corp pays a 1.61% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nokia Corp for 66 Days and Oscar Health Inc for 15 Days on average.

NOKOSCR
Market Cap
$56.99B$10.22B
Volume
69,968,2044,123,394
Sector
TechnologyHealth
52-Week High
$16.83$33.81
52-Week Low
$5.18$10.85
Typical Hold Time
66 Days15 Days
Enterprise Value
$55.01B$6.57B
Dividend Yield
1.61%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nokia Corp

Nokia (NOK) trades at $10.285, down 3.15% today, with a bearish technical signal from moving averages and neutral oscillators. The company reported mixed quarterly earnings, beating in Q4 2025 and Q2 2026 but missing in Q1 2026. Revenue for 2025 was $19.89B with a net income margin of 3.47%. Recent news highlights partnerships in AI and satellite communications, including an expanded collaboration with Microsoft and a defense-focused satellite venture with ICEYE.

The stock presents a valuation challenge with a high P/E of 75.09, though analyst consensus is bullish with a $17.50 price target. Upside potential is supported by AI infrastructure demand and strategic partnerships, but risks include competitive pressures, execution on growth initiatives, and volatile cash flows. The current price is well below the consensus target, indicating significant projected upside if growth catalysts materialize.

Oscar Health Inc

OSCR trades at $33.41, up 1.52% today, with a bullish technical signal and strong recent earnings beats in Q1 and Q2 2026. The stock shows robust revenue growth, with 2026 revenue projected at $15.3B and a return to profitability. Analyst sentiment is mixed but leans positive, with a consensus price target of $34.00. Recent news highlights market share gains and raised 2026 guidance, though the stock faces tests from rising medical costs.

The outlook is cautiously optimistic, driven by scalable growth in the ACA market and margin expansion opportunities. Key risks include medical cost pressures and competitive threats. Upside potential exists if the company executes on its 2029 EPS target of $4+, but investors should monitor profitability sustainability amid cost headwinds.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NOK
92% Buy8% Sell
Avg holding period · 66 Days
OSCR

No sentiment data available yet.

Top news

Latest headlines on both assets

About Nokia Corp

Nokia is a leading vendor in the telecommunications equipment industry. The company's network business derives revenue from selling wireless and fixed-line hardware, software, and services. Nokia's technology segment licenses its patent portfolio to handset manufacturers and makes royalties from Nokia-branded cellphones. The company, headquartered in Espoo, Finland, operates on a global scale, with most of its revenue from communication service providers.

Read more on NOK →

About Oscar Health Inc

Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.

Read more on OSCR →